−32.9
Galmed Pharmaceuticals Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−18.5
FY23:
−6.14
FY24:
−5.88
FY25:
−6.32
Change from FY21 to FY25
millions USD
FY21:
11.5
FY22:
17.6
FY23:
0.80
FY24:
−1.11
FY25:
−3.38
Change from FY21 to FY25
millions USD
FY21:
17.4
FY22:
0.07
FY23:
6.19
FY24:
8.79
FY25:
9.03
millions USD
FY21:
−4.06
FY22:
−0.87
FY23:
0.85
FY24:
1.80
FY25:
−0.66
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.9
FY22:
−18.5
FY23:
–
FY24:
–
FY25:
−6.32
All amounts in millions USD